PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

GEINPYKZLFHHIL-HEXXMCQTSA-N

InChI Key

GEINPYKZLFHHIL-HEXXMCQTSA-N

IUPAC name

[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

PC(15:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

—

ChEBI

CHEBI:170768

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_AONFH_Stage_III_IV
• Control_vs_Exercise
• Control_12h_vs_Toxocara canis_12h
• Control_12h_vs_Toxocara canis_12h